Blake Borgeson

Director · 8 filings · Latest: Aug 4, 2026

RECURSION PHARMACEUTICALS, INC.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
RXRX	Blake Borgeson	Director	Aug 4, 2026	Sale	$3.25	30,000	$97.5K	6,188,287	Aug 6 9:09 PM
RXRX	Borgeson Blake	—	Aug 4, 2026	Proposed Sale	$3.25	30,000	$97.5K	—	Aug 4 5:37 PM
RXRX	Blake Borgeson	Director	Jul 7, 2026	Sale	$3.96	40,000	$158.5K	6,218,287	Jul 9 10:04 PM
RXRX	Borgeson Blake	—	Jul 7, 2026	Proposed Sale	$3.96	40,000	$158.5K	—	Jul 7 3:36 PM
RXRX	Blake Borgeson	Director	Jun 2, 2026	Sale	$3.68	30,000	$110.4K	6,169,863	Jun 4 9:04 PM
RXRX	Borgeson Blake	—	Jun 2, 2026	Proposed Sale	$3.68	30,000	$110.4K	—	Jun 2 3:04 PM
RXRX	Blake Borgeson	Director	May 5, 2026	Sale	$3.52	30,000	$105.6K	6,199,863	May 7 8:44 PM
RXRX	Borgeson Blake	—	May 5, 2026	Proposed Sale	$3.52	30,000	$105.6K	—	May 5 2:22 PM
RXRX	Blake Borgeson	Director	Apr 7, 2026	Sale	$3.10	30,000	$93.0K	6,229,863	Apr 8 8:58 PM
RXRX	Borgeson Blake	—	Apr 7, 2026	Proposed Sale	$3.10	30,000	$93.0K	—	Apr 7 2:17 PM
RXRX	Blake Borgeson	Director	Mar 3, 2026	Sale	$3.46	170,000	$588.2K	6,259,863	Mar 4 9:38 PM
RXRX	Borgeson Blake	—	Mar 3, 2026	Proposed Sale	$3.46	170,000	$588.2K	—	Mar 3 5:45 PM
RXRX	Blake Borgeson	Director	Feb 3, 2026	Sale	$4.20	220,000	$924.0K	6,429,863	Feb 6 10:53 PM
RXRX	Borgeson Blake	—	Feb 3, 2026	Proposed Sale	$4.20	220,000	$924.0K	—	Feb 3 4:26 PM
RXRX	Borgeson Blake	—	Jan 6, 2026	Proposed Sale	$4.36	220,000	$959.2K	—	Jan 6 2:40 PM
RXRX	Borgeson Blake	—	Dec 2, 2025	Proposed Sale	$4.37	220,000	$961.4K	—	Dec 2 5:15 PM
RXRX	Borgeson Blake	—	Nov 12, 2024	Proposed Sale	$7.64	11,447	$87.5K	—	Nov 12 9:40 PM
RXRX	Borgeson Blake	—	Oct 29, 2024	Proposed Sale	$6.72	11,447	$76.9K	—	Oct 29 8:35 PM
RXRX	Borgeson Blake	—	Oct 15, 2024	Proposed Sale	$6.67	11,447	$76.3K	—	Oct 15 8:42 PM
RXRX	Borgeson Blake	—	Oct 1, 2024	Proposed Sale	$6.51	11,447	$74.5K	—	Oct 1 6:20 PM

Page 1 of 2